EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 21st, 2017 • Zomedica Pharmaceuticals Corp. • Pharmaceutical preparations • Delaware
ZOMEDICA PHARMACEUTICALS INC., a body corporate duly incorporated pursuant to the laws of the State of Delaware and having an office in the City of Ann Arbor, Michigan (hereinafter referred to as the "Corporation")
ESCROW AGREEMENT (VALUE SECURITY)Escrow Agreement • April 21st, 2017 • Zomedica Pharmaceuticals Corp. • Pharmaceutical preparations • Alberta
This Agreement is being entered into by the Parties under Exchange Policy 5.4 - Escrow, Vendor Consideration and Resale Restrictions (the Policy) in connection with a Reverse Takeover. The Issuer is a Tier 1 as described in Policy 2.1 - Initial Listing Requirements.
COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • April 21st, 2017 • Zomedica Pharmaceuticals Corp. • Pharmaceutical preparations • Michigan
THIS COLLABORATIVE RESEARCH AGREEMENT (“Agreement”), is made the 3rd day of January, 2017 (the “Effective Date”), by and between Celsee Diagnostics, Inc. whose address is 4670l Commerce Center Drive, Plymouth, MI 48170 (“Celsee”) and Zomedica Pharmaceuticals Corp. whose head office address is 3928 Varsity Drive, Ann Arbor, MI 48018 (“Zomedica”) (Celsee and Zomedica are each a “Party” and collectively the “Parties”).
EMPLOYMENT AGREEMENTEmployment Agreement • April 21st, 2017 • Zomedica Pharmaceuticals Corp. • Pharmaceutical preparations • Michigan
AMENDMENT NO.1 TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 21st, 2017 • Zomedica Pharmaceuticals Corp. • Pharmaceutical preparations
WHEREAS the Corporation and the Executive are parties to an Employment Agreement dated as of July 16, 2016 (the “Employment Agreement”), between the parties and pursuant to which Executive serves as the Company’s Chief Financial Officer; and
